A new plasma framework reframes ignition, sustainment, and degradation, redefining energy behavior for next-generation ...
Learn how Microsoft research uncovers backdoor risks in language models and introduces a practical scanner to detect tampering and strengthen AI security.
Researchers led by Dr. Claire Foldi at Monash University have discovered that psilocybin, the psychoactive compound found in magic mushrooms, produces subtle but distinct effects on social behavior ...
Behavior is at the heart of nearly every challenge in the workplace, from leadership and fair decisions to high performance and AI adoption. But how should organizations go about influencing behavior?
What happens when artificial intelligence becomes too eager to please? Imagine asking an AI for advice, only to realize later that its response was more about agreeing with you than offering accurate ...
The Trump administration has unveiled yet another new payment model, this one focused on the cost of GLP-1 therapies. The Centers for Medicare & Medicaid Services (CMS) on Tuesday announced the Better ...
CMS published plans Dec. 23 for its voluntary “Better Approaches to Lifestyle and Nutrition for Comprehensive hEalth” — or BALANCE — model. The announcement comes weeks following the White House’s ...
Large language models often lie and cheat. We can’t stop that—but we can make them own up. OpenAI is testing another new way to expose the complicated processes at work inside large language models.
1 School of Land Resources and Environment, Jiangxi Agricultural University, Nanchang, China 2 College of Economics and Management, Jiangxi Agricultural University, Nanchang, China Introduction: ...
Large Language Models (LLMs) have transformed natural language processing, yet two fundamental challenges persist: the computational expense of training and the difficulty of precisely controlling ...
Nine years ago, a little show called Stranger Things debuted on Netflix and captured the attention of the world with its winsome ’80s nostalgia, grounded action, and charming cast of mostly ...
After 15 years at Genentech, where his work has spanned small molecules, antibody drug conjugates, and now cell and gene therapies – Don has become one of the company’s most vocal champions for the ...